- By insider
Chairman, President & CEO of Idexx Laboratories Inc (IDXX) Jonathan W Ayers sold 36,000 shares of IDXX on 02/06/2018 at an average price of $179.28 a share. The total sale was $6.5 million.
IDEXX Laboratories Inc develops, manufactures and distributes products and provide services for companion animal veterinary, livestock and poultry, dairy and water testing markets. IDEXX Laboratories Inc has a market cap of $15.42 billion; its shares were traded at around $176.83 with a P/E ratio of 60.13 and P/S ratio of 8.02. IDEXX Laboratories Inc had annual average EBITDA growth of 12.70% over the past ten years. GuruFocus rated IDEXX Laboratories Inc the business predictability rank of 5-star.
-
Warning! GuruFocus has detected 3 Warning Signs with FSIC. Click here to check it out.
-
The intrinsic value of IDXX
CEO Recent Trades:
-
Chairman, President & CEO Jonathan W Ayers sold 36,000 shares of IDXX stock on 02/06/2018 at the average price of $179.28. The price of the stock has decreased by 1.37% since.
-
Chairman, President & CEO Jonathan W Ayers sold 54,000 shares of IDXX stock on 01/11/2018 at the average price of $165.98. The price of the stock has increased by 6.54% since.
CFO Recent Trades:
-
Executive VP & CFO Brian P Mckeon sold 6,602 shares of IDXX stock on 02/05/2018 at the average price of $181.36. The price of the stock has decreased by 2.5% since.
For the complete insider trading history of IDXX, click here
.This article first appeared on GuruFocus.
-
Warning! GuruFocus has detected 3 Warning Signs with FSIC. Click here to check it out.
-
The intrinsic value of IDXX